Secondary Analysis News Today

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...

Research presented at ATS 2024 highlights the clinical benefits of PAP therapy in treating sleep-disordered breathing.

During a session at the American Thoracic Society (ATS) 2024 International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome (ARDS), childhood asthma, health equity, and lung cancer.

The study findings suggest that self-management strategies for hypertension may effectively reduce blood pressure levels over 24 months without increasing healthcare resource utilization or adverse events as compared to usual care.

Highlights include two head-to-head randomized clinical trials data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia -Additional studies examine...

Comparison of prostate cancer mortality rate conducted on subjects with a single invitation for PSA screening.

Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.

A secondary analysis found a brain scan with an AI algorithm predicted within a week 1/3 of patients would respond to sertraline and 2/3 would not.

Patients with fibromyalgia have poorer accuracy for divided attention, mediated by sleep disturbance, according to a new study.

Researchers from Spain investigated the effect of a traditional Atlantic diet on health and the environment.